medigraphic.com
Instituto Nacional de Salud Pública

2010, Número 3

<< Anterior Siguiente >>

salud publica mex 2010; 52 (3)


Propiedades nutraceúticas del licopeno

Waliszewski KN, Blasco G

Idioma: Español
Referencias bibliográficas: 61
Paginas: 254-265
Archivo PDF: 166.91 Kb.


RESUMEN

Las recomendaciones dietarias en los últimos años proponen el incremento del consumo de alimentos que contienen fitoquímicos, ya que éstos proveen efectos benéficos para la salud humana y juegan un papel importante en la prevención de enfermedades crónicas. El licopeno, carotenoide responsable del color rojo de los tomates, ha atraído la atención debido a sus propiedades biológicas y fisicoquímicas en la prevención de enfermedades crónicas como cáncer, enfermedades cardiovasculares y neurodegenerativas, e hipertensión, entre otras, en las cuales el estrés oxidativo es un importante factor etiológico. Los antioxidantes, incluyendo al licopeno, interactúan con las especies reactivas del oxígeno, pudiendo mitigar el efecto dañino y jugar un papel significativo en la prevención de dichas enfermedades. Este artículo presenta una revisión de algunos estudios epidemiológicos realizados en los últimos años acerca de los efectos benéficos del licopeno en la salud humana.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Henson S, Masakure O, Cranfield J. The propensity for consumers to offset health risks through the use of functional foods and nutraceuticals: The case of lycopene. Food Qual Prefer 2008;19:395-406.

  2. Holst B, Williamson G. Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants. Curr Opinion Biotech 2008;19:73-82.

  3. Khachick F, Carvalho, L, Bernstein SP, Muir GJ, Zhao D, Katz NB. Chemistry, distribution, and metabolism of tomato carotenoides and their impact on human health. Exp Biol Med 2002;227:845-851.

  4. Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res 999;19:305-323.

  5. Sthal W, Sies H. Lycopene: a biologically important carotenoid for humans? Arch Biochem Biophys 1996;336:1-9.

  6. Baysal T, Ersus S, Starmans DAJ. Supercritical CO2 extraction of 􀁠-carotene and lycopene from tomato paste waste. J Agric Food Chem 2000;28:5507-5511.

  7. Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med 2002;227:852-859.

  8. Perera CO, Mei Yen G. Functional properties of carotenoides in human health. International J Food Proper 2007;10:201-230.

  9. Pamplona R. El poder medicinal de los alimentos. Colección dimensiones de la salud física. España: Asociación Publicadora Interamericana (APIA), 2005.

  10. Gross J. Pigments in fruits. London: Academic Press, 1987.

  11. Gross J. Pigments in fegetables. New York: Van Nordstrand Teinhold, 1991.

  12. Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. Carotenoids in fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 1993;93:284-296.

  13. Shi J. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Food Sci Nutr 2000;40:1-42.

  14. Hart DJ, Scott KJ. Development and evaluation of an HLPC method for the analysis of carotenoids in foods, and the measurement of the carotenoide content of vegetables and fruits commonly consumed in the UK. Food Chem 1995;54:101-111.

  15. Tonucci LH, Holden JM, Beecher GR, Khachik F, Davis C, Mulokozi G. Carotenoid content of thermally processed tomato-based food products. J Agric Food Chem 1995;43:579-586.

  16. Heinonen MI, Ollilainen V, Linkola EK, Varo PT, Koivistoinen PE. Carotenoids in finnish foods, vegetables, fruits, and berries. J Agric Food Chem 1989;37:655-659.

  17. Lampe C, Watada AE. Postharvest quality of high pigment and crimson tomato fruit. J Amer Soc Hort Sci 1971;96(4):534-535.

  18. Agarwal S, Rao VA. Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 2000;163:739-744.

  19. Cohen L. A review of animal model studies of tomato carotenoides, lycopene, and cancer chemoprevention. Exper Biol Med 2002;227:864-868.

  20. Rao AV, Agarwal S. Bioavaibility and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 1998;31:199-203.

  21. Parker RS. Absorption, metabolism and transport of carotenoids. FASEB J 1996;10:542-551.

  22. Heber HN, Lu Q-L. Overview of mechanisms of action of lycopene. Exper Biol Med 2002;227:920-923.

  23. Wertz K, Siler U, Goralczyk R. Lycopene: Modes of action to promote prostate health. Arch Biochem Biophys 2004;430:127-134.

  24. Rao AV, Ali A. Biologically active phytochemicals in human health: Lycopene. Inter J Food Proper 2007;10:279-288.

  25. World Cancer Research Fund/ American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR, 2007.

  26. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either 􀁟- or 􀁠-carotene. Nutr Cancer 1995;24:257-266.

  27. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colitz GA, Willett WC. Intake of carotenoides and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1994;87:1767-1776.

  28. Chan JM, Stampfer M, Giovannucci EL. What causes prostate cancer? A brief summary of the epidemiology. Cancer Bio 1998;8:263-273.

  29. Omoni AO, Aluko RE. The anti-carcinogenic and anti-atherogenic effects of lycopene: a review. Trends Food Sci Technol 2005;16:344-350.

  30. Kucuk O, Sarkar FH, Sak, W, Djuric Z, Pollak MN, Khachik F, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2002;10:861-868.

  31. Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon BL, et al. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15(1):92-98.

  32. Stram DO, Hankin JH, Wilkens LR, Park S, Henderson BR, Nomura AMY, et al. Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study (United States). Cancer Causes Control 2006;17:1193-1207.

  33. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer. Review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-331.

  34. Rao AV, Ray MR, Rao LG. Lycopene. Adv Food Nutr Res 2006;51:99-164.

  35. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000 Tomo II[monografía en internet]. México, DF: Instituto Nacional de Salud Pública y Secretaría de Salud, 2000 [consultado 2009 enero 20]. Disponible en http://www.insp.mx/ ensa/ensa_tomo2.pdf.

  36. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-796.

  37. Parthasarathy S, Steinberg D, Witztum JL. The role of oxidized lowdensity lipoproteins in pathogenesis of atherosclerosis. Am Rev Med 1992;43:219-225.

  38. Fuhrman B, Elis A, Aviram M. Hypocholesterolemic effect of lycopene and 􀁠-carotene is related to suppression of choresterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun 1997;233:658-662.

  39. Rissanen TH, Voutilainen S, Nyyssonen K, Salonen R, Salonen JT. Low plasma lycopene concentration is associated with increased intima-media thickness of the carotid artery wall. Arteriosclero Thromb Vasc Biol 2003;20:2677-2681.

  40. Rissanen TH, Voutilainen S, Salonen R, Kaplan GA, Salonen JT. Serum lycopene concentration and carotid atherosclerosis: the Kupio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2000;77:133-138.

  41. Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, Witteman JCM. Serum carotenoids and atherosclerosis –The Rotterdam study. Atherosclerosis 2000;148:49-56.

  42. Kohlmeir L, Kark JD, Gómez-García E, Martin BC, Steck SE, Kardinaal AF, et al. Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 1997;146:618-626.

  43. Parthasarathy S. Mechanisms by which dietary antioxidants may prevent cardiovascular diseases. J Med Food 1998;1:45-51.

  44. Agarwal A, Rao AV. Tomato lycopene and low density lipoprotein in oxidation: a human dietary intervention study. Lipids 1998;33:981-984.

  45. Sesso HD, Liu S, Gaziano MJ, Buring JE. Dietary lycopene, tomatobased food products and cardiovascular disease in women. J Nutr 2003;133:2336-2341.

  46. Blum A, Merei M, Karem A, Blum N, Ben-Arzi S, Wirsansky I, et al. Effects of tomatoes on the lipid profile. Clin Exp Med 2006;29:5,298-300.

  47. Kim L, Rao AV, Rao LG. Lycopene II- Efect on osteoblasts: The carotenoide lycopene stimulates cell proliferation and alkaline photophatase activity of SaOS-2 cells. J Med Food 2003;6:79-86.

  48. Park CK, Ishimi Y, Ohmura M, Yamaguchi M, Ikegami S. Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J Nutr Sci Vitaminol 1997;43:281-296.

  49. Rao LG, Mackinno ES, Josse RG, Murray TM, Strauss A, Rao AV. Lycopene consumption decreases oxidative stress and bone resorption makers in postmenopausal women. Osteoporos Int 2007;18:109-115.

  50. Zini A, de Lamirande E, Gagnon C. Reactive oxygen species in semen of infertile patients: levels of superoxide dismutase and catalase-like activities in seminal plasma and spermatozoa. Int J Androl 1993;16:183-188.

  51. Friedman J, Peleg E, Kagan T, Shnizer S, Rosenthal T. Oxidative stress in hypertensive, diabetic, and diabetic hypertensive rats. Am J Hypertens 2003;16:1049-1052.

  52. Lassegue B, Griending KK. Reactive oxygen species in hypertension. Am J Hypertens 2004;17:852-860.

  53. Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 2006;151:100. e6-100.e1

  54. Iwasaki A, Gagnon C. Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil Steril 1992;57:409-416.

  55. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2003;5:291-309.

  56. Mitchell JJ, Paiva M, Heaton MB. Vitamin E and Beta-carotene protect against ethanol combined with ischemia in an embryonic rat hippacapal culture model of fetal alcohol syndrome. Neurosci Lett 1999;263:189-192.

  57. Foy CJ, Passmore AP, Vahidassr MD, Young IS, Lawson JT. Plasma chainbreaking antioxidants in Alzheimer´s disease. QJM 1999;92:39-45.

  58. Sinclair AJ, Bayer AJ, Johnston J, Warner C, Maxwell SR. Altered plasma antioxidants status in subjects with Alzheimer´s disease and vascular dementia. Int J Geriatr Psychiatry 1998;13;840-845.

  59. Clinton SK. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr Rev 1998;1:35-51.

  60. Cooddley GO, Codley MK, Nelson HD. Micronutrients in HIV-infected women. J Womens’ Health 1995;4:303-311.

  61. Periquet BA, Jammes NM, Lambert WE, Tricoire J, Maoussa MM, Garcia J, et al. Micronutrient levels in HIV-1-infected children. AIDS1995;9:887-893.




2020     |     www.medigraphic.com